Takeda Pharmaceutical TAK
NYSE TAK
$17.86 -0.01 (-0.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Takeda Pharmaceutical (TAK) Cash from Discontinued Operations (2019 - 2020)

Updated

Takeda Pharmaceutical (TAK) recorded Cash from Discontinued Operations of $5.51 million in the quarter ended Mar 31, 2020, compared with -$34.52 million a year earlier.

Analysis

Takeda Pharmaceutical (TAK) Cash from Discontinued Operations (2019 - 2020) Analysis & Trends

For the year ended Mar 31, 2019, Takeda Pharmaceutical reported Cash from Discontinued Operations of -$1.82 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.87 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Takeda Pharmaceutical 2.58 Bn -23.92 Bn 5.10 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 5.51 Mn
Sep 30, 2019 5.59 Mn
Mar 31, 2019 -34.52 Mn
API Access

Takeda Pharmaceutical Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=TAK&period=max&api_key=YOUR_API_KEY